0.05% cyclosporine eyedrops

DRUG3 trials

Sponsors

Peking University Third Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

AsthenopiaDry EyeDry Eye Disease (DED)

Phase 4

The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye

Peking University Third HospitalDry Eye

Start: 2022-08-31End: 2023-12-31Target: 60Updated: 2023-09-21

The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease

CompletedNCT06824844

Peking University Third HospitalDry Eye

Start: 2021-12-02End: 2024-06-04Updated: 2025-02-13

Unknown Phase

Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT

CompletedNCT06981104

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityAsthenopia, Dry Eye Disease (DED)

Start: 2024-11-18End: 2025-02-14Updated: 2025-11-20

Related Papers

Efficacy of topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in post-refractive surgery chronic dry eye patients with ocular pain.

2024-01-228 citations